Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
autoimmune disease
Research
Holoclara wriggles into ph. 1, sets sights on immune disease
The drug candidate being tested, HC002, is an oral small molecule that was originally sourced from roundworms that live in our guts.
Darren Incorvaia
Dec 18, 2024 9:05am
Candid unwraps 3 collabs to develop new T-cell engagers
Dec 16, 2024 11:59am
Nuvig raises $161M with 4 Big Pharmas in tow
Dec 5, 2024 7:00am
Cour inks $940M-plus autoimmune deal with Roche's Genentech
Dec 3, 2024 7:58am
BMS' CAR-T cracks down on lupus, achieving sustained responses
Nov 14, 2024 10:00am
VC firm, Chinese biotech launch autoimmune-focused Oblenio Bio
Nov 7, 2024 11:35am
